- Home
- AUPH vs CECO Comparison
AUPH vs CECO Comparison
Compare AUPH & CECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- CECO
- Stock Information
- Founded
- AUPH 1993
- CECO 1966
- Country
- AUPH Canada
- CECO United States
- Employees
- AUPH N/A
- CECO N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- CECO Pollution Control Equipment
- Sector
- AUPH Health Care
- CECO Industrials
- Exchange
- AUPH Nasdaq
- CECO Nasdaq
- Market Cap
- AUPH 1.6B
- CECO 1.7B
- IPO Year
- AUPH 1999
- CECO N/A
- Fundamental
- Price
- AUPH $14.30
- CECO $53.69
- Analyst Decision
- AUPH Strong Buy
- CECO Strong Buy
- Analyst Count
- AUPH 2
- CECO 4
- Target Price
- AUPH $13.00
- CECO $47.50
- AVG Volume (30 Days)
- AUPH 1.5M
- CECO 635.2K
- Earning Date
- AUPH 11-04-2025
- CECO 10-28-2025
- Dividend Yield
- AUPH N/A
- CECO N/A
- EPS Growth
- AUPH N/A
- CECO 334.15
- EPS
- AUPH 0.55
- CECO 1.43
- Revenue
- AUPH $265,808,000.00
- CECO $718,253,000.00
- Revenue This Year
- AUPH $17.33
- CECO $38.58
- Revenue Next Year
- AUPH $14.31
- CECO $10.37
- P/E Ratio
- AUPH $25.94
- CECO $37.60
- Revenue Growth
- AUPH 20.62
- CECO 29.86
- 52 Week Low
- AUPH $6.55
- CECO $17.57
- 52 Week High
- AUPH $16.20
- CECO $54.00
- Technical
- Relative Strength Index (RSI)
- AUPH 74.01
- CECO 58.98
- Support Level
- AUPH $11.96
- CECO $47.08
- Resistance Level
- AUPH $12.70
- CECO $53.51
- Average True Range (ATR)
- AUPH 0.64
- CECO 2.97
- MACD
- AUPH 0.25
- CECO 0.08
- Stochastic Oscillator
- AUPH 61.10
- CECO 96.70
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About CECO CECO Environmental Corp.
CECO Environmental Corp serves the energy, industrial, and other niche markets. The company operates through the Engineered Systems segment that serves the power generation, refinery, water/wastewater, and midstream oil and gas markets, and Industrial Process Solutions segment, which serves the broad industrial air pollution control, beverage can, fluid handling, electric vehicle production, food and beverage, semi-conductor, process filtration, pharmaceutical, petrochemical, wastewater treatment, wood manufacturing, desalination, and aquaculture markets. The majority of revenue is earned from the Engineered Systems Segment.